偉鴻(03321.HK)去年經審覈業績延至不遲於5月15日刊發
偉鴻集團控股(03321.HK)公佈,由於新冠病毒疫情爆發,香港、澳門及中國內地實施更嚴格的防控檢疫措施及限制,導致在取得必要文件及外部審計確認函方面出現延誤。公司已盡最大努力協助核數師完成其審覈工作,但核數師尚未取得完成核數過程所需的必要文件及外部確認函。根據最新進展,需要額外時間對公司截至去年12月底止年度的綜合財務報表進行審覈。因此,去年經審覈年度業績的刊發將進一步延遲。
監於上述情況,預計2021年經審覈年度業績的預期刊發日期及2021年年報的寄發日期將由不遲於今日(4月25日)延遲至5月15日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.